Lung function response to postnatal corticosteroids for the prevention and treatment of bronchopulmonary dysplasia.

IF 3.1 3区 医学 Q1 PEDIATRICS
Camilla Rigotti, Emanuela Zannin, Sofia Chiaraluce, Maria Luisa Ventura
{"title":"Lung function response to postnatal corticosteroids for the prevention and treatment of bronchopulmonary dysplasia.","authors":"Camilla Rigotti, Emanuela Zannin, Sofia Chiaraluce, Maria Luisa Ventura","doi":"10.1038/s41390-024-03535-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Steroid treatment is well-known for producing clinically significant improvements in respiratory support requirements. In this study, we utilized lung ultrasound and respiratory oscillometry to objectively assess this response and determine if the combination of these methods can serve as a valuable tool for comparing different treatment strategies.</p><p><strong>Methods: </strong>We conducted a retrospective observational study including preterm infants with a gestational age below 32 weeks and/or a birth weight below 1500 g. We measured lung ultrasound score (LUS) and respiratory system reactance (Xrs) by respiratory oscillometry before and after treatment with either systemic dexamethasone or inhaled budesonide.</p><p><strong>Results: </strong>We analyzed 46 treatments (9 dexamethasone, 37 budesonide) administered to 40 infants (median (Q1, Q3) postnatal age = 30 (18, 49) days, postmenstrual age = 33.29 (30.14, 35.00) weeks). All treatments were associated with a notable reduction in respiratory support and a concurrent improvement in either Xrs, LUS, or both. On average, Xrs improved from 3.13 (1.09, 5.41) to 0.44 (-0.90, 1.59) z-score (p < 0.001) and LUS from 10 (7, 12) to 5 (3, 8) (p < 0.001).</p><p><strong>Conclusions: </strong>Xrs and LUS proved sensitive to lung function changes associated with corticosteroids; combining the two better described the response and its variability.</p><p><strong>Impact: </strong>We found that respiratory system reactance (Xrs) and lung ultrasound score (LUS) are sensitive biomarker for monitoring changes in lung function associated with corticosteroids; Combining Xrs and LUS enhances evaluation compared to each method alone; These results have valuable implications in clinical practice, particularly in personalizing and monitoring corticosteroid treatment; The present paper suggests that the combined use of respiratory oscillometry and lung ultrasound holds value as a research tool in future studies investigating various treatment regimens, molecules, or administration routes.</p>","PeriodicalId":19829,"journal":{"name":"Pediatric Research","volume":null,"pages":null},"PeriodicalIF":3.1000,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41390-024-03535-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Steroid treatment is well-known for producing clinically significant improvements in respiratory support requirements. In this study, we utilized lung ultrasound and respiratory oscillometry to objectively assess this response and determine if the combination of these methods can serve as a valuable tool for comparing different treatment strategies.

Methods: We conducted a retrospective observational study including preterm infants with a gestational age below 32 weeks and/or a birth weight below 1500 g. We measured lung ultrasound score (LUS) and respiratory system reactance (Xrs) by respiratory oscillometry before and after treatment with either systemic dexamethasone or inhaled budesonide.

Results: We analyzed 46 treatments (9 dexamethasone, 37 budesonide) administered to 40 infants (median (Q1, Q3) postnatal age = 30 (18, 49) days, postmenstrual age = 33.29 (30.14, 35.00) weeks). All treatments were associated with a notable reduction in respiratory support and a concurrent improvement in either Xrs, LUS, or both. On average, Xrs improved from 3.13 (1.09, 5.41) to 0.44 (-0.90, 1.59) z-score (p < 0.001) and LUS from 10 (7, 12) to 5 (3, 8) (p < 0.001).

Conclusions: Xrs and LUS proved sensitive to lung function changes associated with corticosteroids; combining the two better described the response and its variability.

Impact: We found that respiratory system reactance (Xrs) and lung ultrasound score (LUS) are sensitive biomarker for monitoring changes in lung function associated with corticosteroids; Combining Xrs and LUS enhances evaluation compared to each method alone; These results have valuable implications in clinical practice, particularly in personalizing and monitoring corticosteroid treatment; The present paper suggests that the combined use of respiratory oscillometry and lung ultrasound holds value as a research tool in future studies investigating various treatment regimens, molecules, or administration routes.

Abstract Image

产后皮质类固醇对预防和治疗支气管肺发育不良的肺功能反应。
背景:众所周知,类固醇治疗可显著改善临床呼吸支持需求。在本研究中,我们利用肺部超声波和呼吸振荡仪来客观评估这种反应,并确定这些方法的结合是否可作为比较不同治疗策略的重要工具:我们进行了一项回顾性观察研究,研究对象包括胎龄低于32周和/或出生体重低于1500克的早产儿。在使用全身地塞米松或吸入布地奈德治疗前后,我们通过呼吸振荡仪测量了肺部超声评分(LUS)和呼吸系统反应(Xrs):我们对 40 名婴儿(出生后年龄中位数(Q1,Q3)= 30(18,49)天,月经后年龄= 33.29(30.14,35.00)周)接受的 46 次治疗(9 次地塞米松治疗,37 次布地奈德治疗)进行了分析。所有治疗方法都显著减少了呼吸支持,同时改善了Xrs、LUS或两者。平均而言,Xrs 从 3.13 (1.09, 5.41) z 分数改善到 0.44 (-0.90, 1.59) z 分数(P 结论:Xrs 和 LUS 对呼吸支持的敏感性被证明是非常高的:事实证明,Xrs 和 LUS 对与皮质类固醇相关的肺功能变化非常敏感;将两者结合起来能更好地描述反应及其可变性:我们发现,呼吸系统反应(Xrs)和肺部超声评分(LUS)是监测皮质类固醇相关肺功能变化的灵敏生物标志物;与单独使用每种方法相比,将 Xrs 和 LUS 结合使用可提高评估效果;这些结果对临床实践具有重要意义,尤其是在个性化和监测皮质类固醇治疗方面;本文表明,在未来调查各种治疗方案、分子或给药途径的研究中,联合使用呼吸振荡计和肺部超声可作为一种有价值的研究工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pediatric Research
Pediatric Research 医学-小儿科
CiteScore
6.80
自引率
5.60%
发文量
473
审稿时长
3-8 weeks
期刊介绍: Pediatric Research publishes original papers, invited reviews, and commentaries on the etiologies of children''s diseases and disorders of development, extending from molecular biology to epidemiology. Use of model organisms and in vitro techniques relevant to developmental biology and medicine are acceptable, as are translational human studies
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信